160 related articles for article (PubMed ID: 7640141)
1. Comparison of the pharmacokinetics and pharmacodynamics of oral doses of perindopril in normotensive Chinese and Caucasian volunteers.
Anderson PJ; Critchley JA; Tomlinson B; Resplandy G
Br J Clin Pharmacol; 1995 Apr; 39(4):361-8. PubMed ID: 7640141
[TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetics and pharmacodynamics of perindopril in patients with hepatic cirrhosis.
Tsai HH; Lees KR; Howden CW; Reid JL
Br J Clin Pharmacol; 1989 Jul; 28(1):53-9. PubMed ID: 2550045
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the pharmacokinetics and pharmacodynamics of cilazapril between Chinese and Caucasian healthy, normotensive volunteers.
Anderson PJ; Critchley JA; Tomlinson B
Eur J Clin Pharmacol; 1996; 50(1-2):57-62. PubMed ID: 8739812
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the pharmacokinetics and pharmacodynamics of perindopril, cilazapril and enalapril.
Louis WJ; Conway EL; Krum H; Workman B; Drummer OH; Lam W; Phillips P; Howes LG; Jackson B
Clin Exp Pharmacol Physiol Suppl; 1992; 19():55-60. PubMed ID: 1327596
[TBL] [Abstract][Full Text] [Related]
5. Single dose pharmacokinetics of perindopril and its metabolites in hypertensive patients with various degrees of renal insufficiency.
Verpooten GA; Genissel PM; Thomas JR; De Broe ME
Br J Clin Pharmacol; 1991 Aug; 32(2):187-92. PubMed ID: 1657092
[TBL] [Abstract][Full Text] [Related]
6. Experience with perindopril in normal volunteers.
Waeber B; Nussberger J; Perret L; Santoni JP; Brunner HR
Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():35-41. PubMed ID: 2549899
[TBL] [Abstract][Full Text] [Related]
7. Single-dose and steady-state pharmacokinetics and pharmacodynamics of perindopril in hypertensive subjects.
Louis WJ; Workman BS; Conway EL; Worland P; Rowley K; Drummer O; McNeil JJ; Harris G; Jarrott B
J Cardiovasc Pharmacol; 1992 Sep; 20(3):505-11. PubMed ID: 1279299
[TBL] [Abstract][Full Text] [Related]
8. Single and repeated dosing of the converting enzyme inhibitor perindopril to normal subjects.
Bussien JP; d'Amore TF; Perret L; Porchet M; Nussberger J; Waeber B; Brunner HR
Clin Pharmacol Ther; 1986 May; 39(5):554-8. PubMed ID: 3516512
[TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics of perindopril and its effects on serum angiotensin converting enzyme activity in hypertensive patients with chronic renal failure.
Sennesael J; Ali A; Sweny P; Vandenburg M; Slovic D; Dratwa M; Resplandy G; Genissel P; Desche P
Br J Clin Pharmacol; 1992 Jan; 33(1):93-9. PubMed ID: 1311597
[TBL] [Abstract][Full Text] [Related]
10. Short-term and long-term cardiovascular actions of different doses of perindopril in the rabbit.
Fennessy PA; Godwin S; Head GA; Campbell JH; Campbell GR
Pharmacol Res; 1996; 34(3-4):135-41. PubMed ID: 9051705
[TBL] [Abstract][Full Text] [Related]
11. Haemodynamic and humoral effects of oral perindopril, an angiotensin converting enzyme inhibitor, in man.
Lees KR; Reid JL
Br J Clin Pharmacol; 1987 Feb; 23(2):159-64. PubMed ID: 3030387
[TBL] [Abstract][Full Text] [Related]
12. Experience with perindopril in normal volunteers.
Waeber B; Nussberger J; Perret L; Santoni JP; Brunner HR
Clin Exp Hypertens A; 1989; 11 Suppl 2():507-19. PubMed ID: 2605800
[TBL] [Abstract][Full Text] [Related]
13. The haemodynamic and humoral effects of treatment for one month with the angiotensin converting enzyme inhibitor perindopril in salt replete hypertensive patients.
Lees KR; Reid JL
Eur J Clin Pharmacol; 1987; 31(5):519-24. PubMed ID: 3030762
[TBL] [Abstract][Full Text] [Related]
14. The effect of perindopril and hydrochlorothiazide alone and in combination on blood pressure and on the renin-angiotensin system in hypertensive subjects.
Brown CL; Backhouse CI; Grippat JC; Santoni JP
Eur J Clin Pharmacol; 1990; 39(4):327-32. PubMed ID: 2076713
[TBL] [Abstract][Full Text] [Related]
15. The effect of haemodialysis on the pharmacokinetics of perindoprilat after long-term perindopril.
Guérin A; Resplandy G; Marchais S; Taillard F; London G
Eur J Clin Pharmacol; 1993; 44(2):183-7. PubMed ID: 8453964
[TBL] [Abstract][Full Text] [Related]
16. Endocrine and hemodynamic responses to dopamine infusion in the guinea-pig: effects of ACE inhibition with perindopril.
Buisson S; Dalle M; Dauprat-Dalle P; Scalbert E
Arch Int Physiol Biochim Biophys; 1992; 100(5):339-43. PubMed ID: 1282386
[TBL] [Abstract][Full Text] [Related]
17. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.
MacFadyen RJ; Lees KR; Reid JL
Br Heart J; 1991 Sep; 66(3):206-11. PubMed ID: 1657084
[TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetics of perindopril in patients with liver cirrhosis.
Thiollet M; Funck-Brentano C; Grangé JD; Midavaine M; Resplandy G; Jaillon P
Br J Clin Pharmacol; 1992 Mar; 33(3):326-8. PubMed ID: 1576057
[TBL] [Abstract][Full Text] [Related]
19. Acute and chronic effects of perindopril on tissue angiotensin converting enzyme activity.
Mendelsohn FA; Pupic V; Jackson B; Cubela R; Johnston CI
Am J Hypertens; 1991 Mar; 4(3 Pt 2):220S-225S. PubMed ID: 1645981
[TBL] [Abstract][Full Text] [Related]
20. Perindopril. A review of its pharmacokinetics and clinical pharmacology.
Macfadyen RJ; Lees KR; Reid JL
Drugs; 1990; 39 Suppl 1():49-63. PubMed ID: 2407493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
